M. M. Oken - Concepedia

Author

M. M. Oken

University of Minnesota

Also Known As

M M Oken, M Oken, M. M. Oken, M.M. Oken, Martin M. Oken

Publications

952

Citations

H-Index

Concepts

All Affiliations

University of Minnesota Johns Hopkins University Palmetto Hematology Oncology University of Minnesota System Abbott Northwestern Hospital

About

M. M. Oken is an author at University of Minnesota specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	543
2	Immunology	4	4	180
3	Health Sciences	2	2	189
4	Public Health	1	1	84
5	Health Policy	1	1	105

M. M. Oken

Publications

929

Citations

H-Index

Page 1

	Year	Citations
Prophylactic antibiotics for the prevention of early infection in multiple myeloma M. M. Oken, Claire Pomeroy, Daniel Weisdorf, The American Journal of Medicine	1996	126
Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients Stephanie R. Wallace, M. M. Oken, Kathryn L. Lunetta, Cancer	2001	117
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study Richard I. Fisher, Ellen R. Gaynor, Steve Dahlberg, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaSurgical OncologyMedicinePathology	1994	110
Physician knowledge and attitudes about cancer pain management: A survey from the Minnesota cancer pain project Thomas E. Elliott, David M. Murray, Barbara A. Brown‐Elliott, Journal of Pain and Symptom Management Pain TherapyHealth SciencesHealth PolicyPain MedicineHealth Communication	1995	105
Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease. F J Cummings, Ki Wook Kim, Richard S. Neiman, Journal of Clinical Oncology ImmunologyPathologyMetronomic ChemotherapyDermatologyImmunotherapy	1991	90
Improving cancer pain management in communities: Main results from a randomized controlled trial Thomas E. Elliott, David M. Murray, M. M. Oken, Journal of Pain and Symptom Management Pain TherapyPain ResearchHealth SciencesPain MedicineMedicine	1997	84
Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma. John Hamm, Joan H. Schiller, C. Cuffie, Journal of Clinical Oncology	1994	57
Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia. Peter A. Cassileth, C B Begg, R Silber, PubMed Hematological MalignancyContinuous Complete RemissionOncologyIntensive Consolidation TherapyMixed-phenotype Acute Leukemia	1987	51
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma M. M. Oken, Traci Leong, Raymond E. Lenhard, Cancer	1999	50
Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia. M. M. Oken, Manuel E. Kaplan PubMed Hematological MalignancyLymphoid NeoplasiaCombination ChemotherapyMedicineImmunology	1979	39

Page 1